Author/Authors :
Zadhoush, Fouzieh Department of Clinical Biochemistry - School of Pharmacy and Pharmaceutical Sciences , Pourfarzam, Morteza Department of Clinical Biochemistry - School of Pharmacy and Pharmaceutical Sciences , Sadeghi, Masoumeh Isfahan Cardiovascular Research Institute - Isfahan University of Medical Sciences, Isfahan
Abstract :
Background: Multiple factors are involved in the development and progression of type 2 diabetes mellitus (DMII) to DMII
with metabolic syndrome (MetS) and cardiovascular complications. To identify some of these factors, we aim to investigate
the changes in erythrocyte membrane Na+/K+-ATPase activity, serum glucose, insulin, lipid profi le, hemoglobin A1C (HbA1c),
high-sensitivity C-reactive protein (hs-CRP), anthropometric measurements, and blood pressure in DMII with and without MetS.
Materials and Methods: Th is cross-sectional study comprised 155 male subjects distributed into three groups as healthy controls
(50 non-DMII volunteers), Group I (50 DMII without MetS), and Group II (55 DMII with MetS). Fasting blood samples were taken
for the measurement of glucose, insulin, HbA1c, hs-CRP and lipid profi le. Na+/K+-ATPase activity was determined in erythrocyte
ghost. Results: Na+/K+-ATPase activity was signifi cantly decreased in DMII groups compared with controls. No signifi cant diff erence
was shown in Na+/K+-ATPase activity between DMII groups. Total ATPase activity, total cholesterol and low-density lipoproteincholesterol
levels were similar in the three groups. Levels of insulin, hs-CRP, triacylglycerols, systolic blood pressure, weight, waist
and hip circumference, waist/hip ratio, and body mass index were signifi cantly elevated and high-density lipoprotein-cholesterol
signifi cantly decreased only in Group II. Signifi cant diff erences in serum glucose and hip circumference were seen between the groups.
No signifi cant diff erences in HbA1c levels were observed between DMII groups. Conclusion: Changes in many of the measured risk
factors that occurred only in Group II compared with controls and Group I may provide an explanation of how DMII progresses to
DMII with MetS and future cardiovascular complications.
Keywords :
type 2 diabetes , Na+/K+-ATPase activity , metabolic syndrome , Lipid profi le